| Financial Year |
March 31 2023 |
| Monetary Funds |
668,551,859.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
60,043,030.48 |
| Accounts Receivable |
2,045,195,912.79 |
| Advances to Suppliers |
7,239,774.31 |
| Other Receivables |
55,839,355.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,196,199,114.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
558,584,777.60 |
| Total Current Assets |
4,870,007,591.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
61,806,250.13 |
| Investment Properties |
-- |
| Fixed Assetes |
173,691,553.58 |
| Under-construction Projects |
52,590,783.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
417,502,248.87 |
| R&D expenses |
15,326,767.42 |
| Goodwill |
311,218,904.57 |
| Long-Term Deferred and Prepaid Expenses |
91,704,185.29 |
| Deferred Income Tax Assets |
115,900,854.02 |
| Other Non-Current Assets |
9,701,096.44 |
| Sub-Total of Non-Current Assets |
1,399,083,754.67 |
| Total Assets |
6,269,091,345.84 |
| Short-Term Loans |
405,184,524.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
183,269,278.05 |
| Accounts Payable |
1,480,743,998.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
133,708,639.17 |
| Taxes Payable |
109,390,431.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
169,830,552.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
127,796,907.51 |
| Other Current Liabilities |
14,220,156.47 |
| Sub-Total of Current Liabilities |
2,687,574,949.88 |
| Long-term Loans |
844,573,014.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,603,405.21 |
| Special Payable |
-- |
| Estimatied Liabilities |
108,554,888.94 |
| Deferred Income Tax Liabilities |
33,627,222.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,023,691,045.36 |
| Total Liabilities |
3,711,265,995.24 |
| Paid-In Capital(Or Share Stock) |
631,490,432.00 |
| Capital Surplus |
630,341,112.21 |
| Surplus Reserve |
126,499,832.42 |
| LESS:Treasury Stock |
39,565,786.08 |
| Undistributed Profits |
1,188,292,894.11 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,557,825,350.60 |
| Owner's Equity（Stockholder's Equity） |
2,557,825,350.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,269,091,345.84 |
